e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pathobiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nerve growth factor expression and function in pulmonary arterial hypertension
V. Freund-Michel, F. Laroumanie, M. Salagiesrka, M. Dubois, A. Courtois, M. Autissier, C. Guibert, J. P. Savineau, R. Marthan, B. Muller (Bordeaux, France)
Source:
Annual Congress 2010 - Pathobiology of pulmonary hypertension
Session:
Pathobiology of pulmonary hypertension
Session type:
Thematic Poster Session
Number:
1080
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Freund-Michel, F. Laroumanie, M. Salagiesrka, M. Dubois, A. Courtois, M. Autissier, C. Guibert, J. P. Savineau, R. Marthan, B. Muller (Bordeaux, France). Nerve growth factor expression and function in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1080
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Potential role of the nerve growth factor NGF in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Role of Connexin 43 increased expression in pulmonary arterial hyperreactivityinduced by the nerve growth factor NGF
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Expression and role of the nerve growth factor NGF in pulmonary hypertension
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression
Source: Eur Respir J 2007; 30: Suppl. 51, 53s
Year: 2007
Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Source: Eur Respir J 2007; 29: 1094-1104
Year: 2007
Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006
Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Vascular endothelial growth factor levels in active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 610s
Year: 2002
Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Possible role of imatinib in clinical pulmonary veno-occlusive disease
Source: Eur Respir J 2008; 32: 232-235
Year: 2008
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
Source: Eur Respir J 2009; 34: 662
Year: 2009
VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept